Compile Data Set for Download or QSAR
Found 76 Enz. Inhib. hit(s) with all data for entry = 6579
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139889(US8895592, 19)copy SMILEScopy InChI
Affinity DataKi:  0.150nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139889(US8895592, 19)copy SMILEScopy InChI
Affinity DataKi:  0.730nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139900(US8895592, 30)copy SMILEScopy InChI
Affinity DataKi:  0.75nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139906(US8895592, 37)copy SMILEScopy InChI
Affinity DataKi:  0.770nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139902(US8895592, 32)copy SMILEScopy InChI
Affinity DataKi:  0.820nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139893(US8895592, 23)copy SMILEScopy InChI
Affinity DataKi:  0.950nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139907(US8895592, 38)copy SMILEScopy InChI
Affinity DataKi:  1.10nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139887(US8895592, 17)copy SMILEScopy InChI
Affinity DataKi:  1.10nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139885(US8895592, 15)copy SMILEScopy InChI
Affinity DataKi:  1.10nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139872(US8895592, 2)copy SMILEScopy InChI
Affinity DataKi:  1.10nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139902(US8895592, 32)copy SMILEScopy InChI
Affinity DataKi:  1.20nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139888(US8895592, 18)copy SMILEScopy InChI
Affinity DataKi:  1.40nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139905(US8895592, 36)copy SMILEScopy InChI
Affinity DataKi:  1.40nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139895(US8895592, 25)copy SMILEScopy InChI
Affinity DataKi:  1.5nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139906(US8895592, 37)copy SMILEScopy InChI
Affinity DataKi:  1.60nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139901(US8895592, 31)copy SMILEScopy InChI
Affinity DataKi:  1.70nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139899(US8895592, 29)copy SMILEScopy InChI
Affinity DataKi:  2nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139905(US8895592, 36)copy SMILEScopy InChI
Affinity DataKi:  2.10nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139907(US8895592, 38)copy SMILEScopy InChI
Affinity DataKi:  2.30nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139878(US8895592, 8)copy SMILEScopy InChI
Affinity DataKi:  2.40nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139899(US8895592, 29)copy SMILEScopy InChI
Affinity DataKi:  2.5nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139896(US8895592, 26)copy SMILEScopy InChI
Affinity DataKi:  2.5nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139872(US8895592, 2)copy SMILEScopy InChI
Affinity DataKi:  3.10nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139895(US8895592, 25)copy SMILEScopy InChI
Affinity DataKi:  3.60nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139878(US8895592, 8)copy SMILEScopy InChI
Affinity DataKi:  5nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139874(US8895592, 4)copy SMILEScopy InChI
Affinity DataKi:  5.20nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139886(US8895592, 16)copy SMILEScopy InChI
Affinity DataKi:  5.20nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139891(US8895592, 21)copy SMILEScopy InChI
Affinity DataKi:  5.40nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139893(US8895592, 23)copy SMILEScopy InChI
Affinity DataKi:  6.70nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139873(US8895592, 3)copy SMILEScopy InChI
Affinity DataKi:  7.40nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139896(US8895592, 26)copy SMILEScopy InChI
Affinity DataKi:  7.40nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139879(US8895592, 9)copy SMILEScopy InChI
Affinity DataKi:  7.70nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139897(US8895592, 27)copy SMILEScopy InChI
Affinity DataKi:  8.40nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139873(US8895592, 3)copy SMILEScopy InChI
Affinity DataKi:  8.70nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139874(US8895592, 4)copy SMILEScopy InChI
Affinity DataKi:  9nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139879(US8895592, 9)copy SMILEScopy InChI
Affinity DataKi:  9.20nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139891(US8895592, 21)copy SMILEScopy InChI
Affinity DataKi:  9.30nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139885(US8895592, 15)copy SMILEScopy InChI
Affinity DataKi:  9.90nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139897(US8895592, 27)copy SMILEScopy InChI
Affinity DataKi:  10nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139877(US8895592, 7)copy SMILEScopy InChI
Affinity DataKi:  12nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139884(US8895592, 14)copy SMILEScopy InChI
Affinity DataKi:  13nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139900(US8895592, 30)copy SMILEScopy InChI
Affinity DataKi:  15nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139904(US8895592, 35)copy SMILEScopy InChI
Affinity DataKi:  15nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139888(US8895592, 18)copy SMILEScopy InChI
Affinity DataKi:  16nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139901(US8895592, 31)copy SMILEScopy InChI
Affinity DataKi:  17nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139875(US8895592, 5)copy SMILEScopy InChI
Affinity DataKi:  18nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139871(US8895592, 1)copy SMILEScopy InChI
Affinity DataKi:  19nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139882(US8895592, 12)copy SMILEScopy InChI
Affinity DataKi:  26nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
AbbVie Inc.

US Patent
LigandPNGBDBM139871(US8895592, 1)copy SMILEScopy InChI
Affinity DataKi:  27nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
TargetCannabinoid receptor 2(Rattus norvegicus (Rat))
AbbVie Inc.

US Patent
LigandPNGBDBM139904(US8895592, 35)copy SMILEScopy InChI
Affinity DataKi:  28nMAssay Description:The CB1 and CB2 radioligand binding assays described herein are utilized to ascertain the selectivity of compounds of the present application for bin...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2CV4GDBUS Patent
Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: